Results 341 to 350 of about 9,625,606 (401)

Management Aspects of Medical Therapy in Graves Disease. [PDF]

Endocr Pract
Shah R, Adamson SE, Jasim S.
europepmc   +1 more source

Application of Thyroid Hormones in Women's Hair for the Non-Invasive Prediction of Graves' Disease. [PDF]

Biomolecules
Igarashi K, Takita C, Matsumoto M, Kitagawa W, Ota A, Miyazaki N, Ito K, Ikeda K.   +7 more
europepmc   +1 more source

Effect of micronutrients on the risk of Graves' disease: a Mendelian randomization study. [PDF]

Front Nutr
Chen F, Qiu R, Lin Z, Chen J, Liu P, Huang Y.   +5 more
europepmc   +1 more source

From Passive Monitoring to Active Control: Aggregation‐induced Emission‐driven Antimicrobial Nanotechnology for Long‐duration Spaceflight

Aggregate, EarlyView.
Feiyi Sun, Nuomin Li, Zheng Zhao, Zicong Zhang, Zuowan Zhou, Xiaoling Xu, Congwen Liu, Qihuan Xiong, Jianmin Tang, Chunhua Yang, Shiyong Yu, Ying Zhang, Ben Zhong Tang, Yulin Deng   +13 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Two cases of Graves' disease following SARS-CoV-2 vaccination: An autoimmune/inflammatory syndrome induced by adjuvants.

Thyroid, 2021
Background: The autoimmune/inflammatory syndrome induced by adjuvants (ASIA) comprises four entities, including the post-vaccination phenomenon, which appears after being exposed to adjuvants in vaccines that increase the immune response.
O. Vera-Lastra, Alberto Ordinola Navarro, Maria Pilar Cruz Domiguez, G. Medina, Tania Ivonne Sanchez Valadez, L. Jara   +5 more
semanticscholar   +1 more source

Can we predict relapse in Graves' disease? Results from a systematic review and meta-analysis.

European Journal of Endocrinology, 2017
BACKGROUND Identification of pretreatment risk factors predicting relapse in patients with hyperthyroidism of Graves' disease after stopping anti-thyroid drugs (ATD) is decisive to guide therapeutic options. PURPOSE We performed a systematic search and
T. Struja, H. Fehlberg, A. Kutz, Larissa Guebelin, Christian Degen, B. Mueller, P. Schuetz   +6 more
semanticscholar   +1 more source

Graves' disease in clinical perspective.

Frontiers in Bioscience, 2019
Graves' disease (GD) is the most common cause for hyperthyroidism in iodine-replete areas. The disease is caused by the appearance of stimulating TSH receptor autoantibodies (TRAb) leading to hyperthyroidism. Blocking and neutral TRAb have, however, also
M. Ehlers, M. Schott, S. Allelein
semanticscholar   +1 more source

L.A.T.S. AND GRAVES' DISEASE

The Lancet, 1970
link_to_subscribed_fulltext
Ross, IP, Hedley, AJ, Crooks, J
openaire   +4 more sources